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A B S T R A C T
Epithelial–mesenchymal transition (EMT) is supposed to be an inﬂammation induced response which
may take a central role in tumorigenesis. Since recent evidence indicates that microRNAs may be in-
volved in EMT, the present study set out to reveal the miRNA which might regulate the EMT in CP (chronic
pancreatitis) and PC (pancreatic cancer) and its potential mechanism. Firstly, we provided evidence that
both CP and PC tissues demonstrated active EMT proﬁle. Consistently, miR-217 was obviously down-
regulated in CP, PC and TGF-β1 treated PC cells, while negatively correlated to its direct target SIRT1.
Moreover, either ectopic expression of miR-217 or inhibition of SIRT1 remarkably induced mesenchy-
mal to epithelial transition (MET) in TGF-β1 treated PC cells. On the contrary, miR-217 inhibitor promoted
EMT in PC cells but not in SIRT-knockdown PC cells. Clinical information from a cohort of 54 PC pa-
tients demonstrated that down-regulatedmiR-217was positively correlatedwith late tumor stage, lymphatic
invasion, vascular inﬁltration and distant metastasis. These results suggest that the overexpressed TGF-
β1 in inﬂammation triggers the deregulation of the miR-217–SIRT1 pathway and then promotes the EMT
process, which might be involved in the tumorigenesis of PC. Additionally, miR-217 may function as a
novel target and predictor for PC prevention and therapy.
© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Introduction
Pancreatic cancer is the fourth leading cause of cancer deaths
in the USA in both sexes with <5% survival after 5 years [1]. Re-
cently, epidemiological and experimental data demonstrated close
connection between chronic pancreatitis (CP) and pancreatic cancer
(PC) [2–4]. However, the mechanism of tumorigenesis from CP to
PC is far from deﬁned. Recent research suggested that the epithe-
lial to mesenchymal transition (EMT) might take center stage as the
convergence point between chronic inﬂammation and cancer [5].
The EMT process is characterized as a change in cell shape from ep-
ithelial to mesenchymal-like, with the down-regulation of epithelial
markers and the up-regulation of mesenchymal markers [6]. The
cell acquires the capacity to degrade the basement membrane and
migrate through the extracellular matrix either during embryonic
development or cancer progression [7,8]. Hotz et al. showed that
the EMT transcription factors Snail and Slug were expressed in pan-
creatic cancer but not in normal pancreas, suggesting a role in the
progression of human pancreatic tumors [9]. Javle et al. also re-
vealed that the EMT markers were associated with poor survival
in surgically resected pancreatic adenocarcinoma [10]. Moreover,
TGF-β1, the important inﬂammatory cytokine which overexpressed
both in chronic pancreatitis and pancreatic cancer [11,12], was re-
garded as promoter of tumor progression and the activator of EMT
[7]. Therefore, these results suggested that EMT might be involved
in the tumorigenesis from CP to PC. However, the EMT proﬁles in
CP have yet to be fully characterized. Therefore, the present study
set out to ﬁrst explore whether the active EMT process also exists
in CP to further reveal whether EMT is involved in the tumorigen-
esis from CP to PC.
MicroRNAs (miRNAs) are small non-coding RNAs that bind the
3’UTR of mRNAs, which result in the degradation or translation
inhibition of the target mRNAs. It was revealed that miRNA expres-
sion could be dynamically regulated in response to speciﬁc immune
and inﬂammatory stimuli under the inﬂammatory microenviron-
ment. Aberrantly expressed miRNA is frequently associated with
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a variety of cancers, including pancreatic cancer [13–15]. Among
those miRNAs, miR-217 was remarkably down-regulated both in
pancreatic cancer withmicroRNAmicroarray analysis [16]. Azevedo-
Pouly et al. revealed that pancreatic acinar ductal trans-differentiation
complicated with decreased miR-217 [17]. Therefore, these results
suggested that miR-217 might be involved in the tumorigenesis
of PC from CP. Given that miRNA has potential functions in carci-
nogenesis of PC from CP, it is of prime interest to conﬁrm whether
both CP and PC existing active EMT process and is regulated by
miRNA.
Since a single miRNA can target multiple mRNAs, we applied the
online software, MicroRNA to predict the downstream target genes
of miR-217. The results showed that silent information regulator 1
(SIRT1) might be a potential target of miR-217. SIRT1 is a mamma-
lian NAD+-dependent class III histone deacetylase (HDAC) which
connects with crucial stress-responsive signal transduction path-
ways including inﬂammation [18,19]. Our previous research showed
that SIRT1 was overexpressed in PC and might function as a pro-
moter in tumorigenesis of PC [4].Moreover,Wauters et al. also proved
that overexpressed SIRT1 regulated acinar to ductal metaplasia and
supported cancer cell viability in pancreatic cancer [20]. Further-
more, other evidence demonstrated that SIRT1 served as a promoter
in EMTprocess by cooperatingwith EMT transcription factors in pros-
tate cancer cell [21].
Therefore,wehypothesize that thedown-regulatedmiR-217might
up-regulate the expression of SIRT1 and then facilitate the EMT in
CP and PC. We detected the miR-217–SIRT1 signaling pathway both
in the CP and PC tissues to reveal whether this pathwaywas deregu-
lated and correlatedwith the EMTproﬁle. Then,we further explored
whether themiR-217–SIRT1pathway could regulate the EMTprocess
of pancreatic cancer cells in an in vitro EMTmodelwhichwas induced
byTGF-β1. Finally, correlation betweenmiR-217 expression and clini-
copathological characteristics of patients with PC were evaluated.
Materials and methods
Patients and tissue samples
Fifty-four pancreatic cancer samples (PC) were collected from patients with pan-
creatic ductal adenocarcinoma (PDAC) who had not received any radiotherapy or
chemotherapy before excision. Chronic pancreatitis samples (CP) were obtained from
26 patients with pancreatic duct stones or pancreatic calciﬁcation. Twenty-seven
normal pancreas samples (NP) were taken from peripheral tissues of serous cyst-
adenoma or insulinoma. The original histopathological reports were obtained from
each case and the diagnosis of pancreatic cancer was conﬁrmed. Immediately after
surgical removal, tissue samples were either snap-frozen in liquid nitrogen or ﬁxed
in 10% buffered formalin solution and then embedded in paraﬃn, respectively. The
patients were all informed that the samples might be applied for further scientiﬁc
research. All participants provided their written consent to participate in this study
before operation and the study protocol was approved by the ethics committee of
Huazhong University of Science and Technology.
Cell culture
The human pancreatic cancer cell lines BxPC-3, PANC-1 were cultured as de-
scribed previously [15]. Cells were treated with 10 ng/ml human TGF-β1 to induce
EMT [22].
Quantitative real-time PCR
Quantitative real-time PCR (qPCR) were performed according to the manufa-
cturer’s protocol (TaKaRa) and the corresponding data analysis was described earlier
[15]. The expression of mRNAs andmiRNAs was normalized with reference to GAPDH
and U6 small nuclear RNA respectively. Primers sequence used to amplify genes are
listed in the Supplementary Table S1.
MicroRNA transfection and RNA interference
A ﬁnal concentration of 50 nM miR-217 precursor, miR-217 inhibitor, siSIRT1
and their matched control was used in microRNA transfection and RNA interfer-
ence. Detailed materials and procedure for microRNA transfection and RNA
interference are given in the Supplementary Methods.
Luciferase reporter assay
The pmiR-RB-ReportTM-SIRT1 (wild type SIRT1 3’UTR, WT) and pmiR-RB-
ReportTM–Control (mutant type SIRT1 3’UTR, MUT) was purchased from RIBOBIO
(Guangzhou, China). PANC-1 cells were seeded in 24-well plates (70–80% conﬂu-
ence) and transfected with pmiR-RB-ReportTM-SIRT1 or pmiR-RB-ReportTM–
Control (200 ng/well) (RIBOBIO) by Lipofectamine 2000 (Invitrogen). Cells were co-
transfected with 50 nM miR-217 or 50 nM miR-NC respectively. Luciferase activity
was determined using the dual luciferase assay system (Promega; Madison, WI)
after 48 h of transfection. Luciferase activity was normalized to Renilla luciferase
activity.
Western blot analysis, immunohistochemistry and immunoﬂuorescence
Cells were lysed in the presence of 50 mM Tris, pH 7.5, 150 mM NaCl, and 1%
NP-40 on ice. Equal amounts of protein were denatured in SDS sample buffer and
separated on 8%, 10%, 12% polyacrylamide gels and transferred to PVDF mem-
branes. The blots were then probedwith various antibodies, such as antibodies against
β-catenin, Vimentin, MMP-2, GAPDH, and E-cadherin. Immunohistochemistry and
immunoﬂuorescence are performed as described [9]. Detailed data for antibodies
and procedures of western blot, immunohistochemistry and immunoﬂuorescence
were given in the Supplementary Methods.
Cell invasion and migration assay, wound healing assay
Cells (2 × 104 to 6 × 104) were plated in 200 μl RPMI 1640mediumwith 0.1% fetal
bovine serum into the upper chamber. The lower chamber was ﬁlled with 700 μl
RPMI 1640 medium with 30% fetal bovine serum. Migration assay were done using
Transwell chambers without coating of ECM gel. Detailed wound healing assay
methods are also given in the Supplementary Methods.
Soft agar colony formation assay
Cells (1250 cells/well) were suspended in 10% FBS-RPMI 1640 containing 0.3%
agar. The cells were then placed into a 24-well culture plate containing a hard agar
base composed of 10% FBS-RPMI 1640 and 0.5% agar. The cultures were returned
to the incubator and fed every 2 days with 250 μl of growth medium. The plates
were incubated for 2 weeks. And then, the cells were stained with 0.05% crystal violet
overnight at 37 °C. Colonies were visualized and counted by light microscopy. Soft
agar assay were performed in triplicate.
Statistical analysis
Data are presented as the mean ± standard deviation. The data were analyzed
using the SPSS 13.0 Windows version software. Statistical analyses were done by
analysis of variance (ANOVA) or Student’s t test. P value <0.05 was considered
statistically signiﬁcant.
Results
Both CP and PC tissues demonstrated active EMT proﬁles
As no comprehensive data set describing EMT proﬁles in normal
pancreas (NP), chronic pancreatitis (CP), and pancreatic cancer (PC)
tissues is currently available, we ﬁrst sought to characterize the EMT
proﬁles in these three types of pancreatic tissues. The expression
of epithelial marker (E-cadherin), mesenchymalmarker (N-cadherin),
EMT inducing transcription factors (Snail and ZEB1) in CP and PC
tissues were compared with NP tissue by qPCR and IHC. As shown
in Fig. 1A, compared to NP tissues, E-cadherin mRNA was signiﬁ-
cantly down-regulated in CP and PC tissues (p < 0.05), whereas there
was no signiﬁcant difference between CP and PC. On the contrary,
mRNAs of N-cadherin, Snail and ZEB1 in CP and PC tissues were sig-
niﬁcantly up-regulated (p < 0.05). On the other hand, IHC results
showed that 75.6% CP, 70.3% PC and 33.3% NP tissues demon-
strated positive N-cadherin expression, respectively. Snail was
positively expressed in 79.3% CP, 80.3% PC and 46.2% NP samples.
Similarly, ZEB1 expressionwas also higher in CP (72.0%) and PC (83.3)
than that in NP (30.0%) samples. Whereas, only 19.2% CP and 25.6%
PC samples showed positive E-cadherin expression, which was lower
than that in NP tissues (60.3%) (Fig. 1B and C).
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To further verify the active EMTprocess in CP andPC tissues, double-
labeled immunoﬂuorescence for E-cadherin and Vimentin, themaster
regulator of cell architecture upon induction of EMT [23] was per-
formed. Compared toNP, E-cadherin stainingwas signiﬁcantlydecreased
in both CP and PC, while Vimentin expression was signiﬁcantly up-
regulated. Moreover, both CP and PC tissues demonstrated signiﬁcant
co-localization of E-cadherin andVimentin,which implied that an active
EMT process was present in both CP and PC tissues (Fig. 2).
Fig. 1. Expression of EMT markers in NP, CP and PC tissues. (A) The relative fold changes of E-cadherin, N-cadherin, Snail, and ZEB1 measured by quantitative real-time
PCR in NP, CP and PC tissues; (B) Immunohistochemical analysis of E-cadherin, N-cadherin, Snail, and ZEB1 in representative tissues from NP, CP and PC group (×400);
(C) The positive expression of E-cadherin, N-cadherin, Snail and ZEB1 was compared with Chi-square analysis. GAPDH was used as the endogenous control. Values are
signiﬁcant at *p < 0.05.
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MiR-217 was signiﬁcantly decreased in CP and PC specimens as well
as the TGF-β1 treated PC cells lines
Since the results demonstrated that both CP and PC demon-
strated active EMT proﬁles, we further detected whether
miR-217 was involved in the EMT of CP and PC. Compared
with NP, miR-217 was signiﬁcantly decreased in CP and PC
tissues (p < 0.05) (Fig. 3A). In addition, we found that miR-217
was positively correlated with E-cadherin expression (r = 0.6420)
(Fig. 3B), while negatively correlated with N-cadherin (r = −0.5292)
expression (Fig. 3C). As shown in Supplementary Fig. S1, after
incubated in medium with 10 ng/ml human TGF-β1 for 72 h,
both BxPC-3 and PANC-1 cells showed obvious EMT proﬁles.
Similar with CP and PC, the TGF-β1 treated cells exhibited a
gradual decrease in miR-217 expression (Fig. 3D). Therefore,
both the clinical and in vitro experiment results validated that
down-regulated miR-217 correlated with the active EMT in CP
and PC.
Fig. 2. Active EMT process in NP, CP and PC tissues was demonstrated with double-labeled immunoﬂuorescence for E-cadherin and Vimentin. E-cadherin+ (red) staining
was more frequently found in epithelial-like pancreatic cells while Vimentin+(green) staining in elongated, mesenchymal-like cells. Co-localization demonstrated in merged
image and nuclei are stained blue with DAPI (×400). A magniﬁed portion of bottom left of fourth row demonstrating a mixed phenotype of E-cadherin (red) and Vimentin
(green) indicated by arrows, implying an active EMT process taking place and there was signiﬁcantly more mixed phenotype cells in CP and PC tissues than that in NP tissues.
(For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 3. MiR-217 expression in NP, CP and PC specimens as well as TGF-β1 treated PC cells. (A) MiR-217 was measured by quantitative real-time PCR in NP, CP and PC tissues;
(B) The miR-217 was positively correlated with E-cadherin expression (r = 0.6420); (C) The miR-217 was antagonistically associated N-cadherin expression (r = −0.5029).
(D) Quantitative real-time PCR showed expression of miR-217 was signiﬁcantly decreased in TGF-β1 treated BxPC-3 and PANC-1 cells in a time-dependent manner. U6 was
used as the endogenous control for miR-217 and GAPDH for E-cadherin and N-cadherin. Values are signiﬁcant at *p < 0.05.
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Restoration of miR-217 reversed EMT in the TGF-β1 treated BXPC-3
and PANC-1 cell lines
The miR-217 mimic (pre-miR-217) was transfected into TGF-
β1 treated pancreatic cancer cells to observe whether restoration
of miR-217 could reverse the EMT-like transformation in those cells.
After treated with miR-217 mimic for 48 h (Fig. 4A), the TGF-β1
treated pancreatic cancer cells (BxPC-3-T72h and PANC-1-T72h)
showed a dramatic MET-like transformation with signiﬁcant up-
regulation of E-cadherin, as well as down-regulation of N-cadherin
andMMP-2 (Fig. 4B). Moreover, invasion (left) andmigration (middle)
ability, as well as cell motility (right) were obviously decreased
(Fig. 4C).
Inhibition of miR-217 induced the EMT proﬁle in BXPC-3 and
PANC-1 cell lines
To further verify whether the down-regulated miR-217 contrib-
ute to EMT of PC cells, we further investigated whether inhibition
of miR-217 could also induce EMT-like transformation in normal
PC cells. As shown in Fig. 4D, inhibition of miR-217 in BxPC-3 and
PANC-1 cells induced signiﬁcant down-regulation of E-cadherin, up-
regulation of N-cadherin and MMP-2 (Fig. 4E), as well as increased
invasion (left), migration ability (middle) and cell motility (right)
(Fig. 4F).
SIRT1 was the direct target for miR-217
Since our previous results showed that SIRT1 was signiﬁcantly
up-regulated in chronic pancreatitis and pancreatic cancer, as well
as the bioinformatics software TargetScan 5.2 and PicTar pre-
dicted miRNA responsive elements within the 3’UTR of SIRT1 as
putative miR-217 targets (Fig. 5A), we further evaluated whether
the SIRT1 was the direct target for miR-217.
First, the ability of miR-217 to regulate the 3’UTR of SIRT1 was
conﬁrmed via luciferase reporter assays. The pmiR-RB-ReportTM-
SIRT1 and pmiR-RB-ReportTM–Control were co-transfected with
miR-217 mimic into PANC-1 cells respectively. As shown in Fig. 5B,
miR-217 inhibited the luciferase activity of the reporter with wild
type 3’UTR of SIRT1, but without obvious effect onmutant type 3’UTR
of SIRT1. To further identify whether miR-217 regulated EMT of PC
cells through targeting SIRT1, the SIRT1 expression in clinical speci-
mens and TGF-β1 treated PC cells was evaluated. The results showed
that SIRT1 was signiﬁcantly increased both in CP and PC samples,
and a signiﬁcant reverse correlation was found between miR-217
and SIRT1 in PC clinical samples (r = −0.7043) (Fig. 5C). After incu-
bation with TGF-β1 for 72 h, BxPC-3 and PANC-1 cells exhibited a
gradual increase of SIRT1 expression (Fig. 5D). Moreover, restora-
tion of miR-217 led to a remarkable decrease in SIRT1 both in mRNA
and protein levels in BxPC-3-T72h and PANC-1-T72h cells, while in-
hibition of miR-217 decreased SIRT1 expression both in mRNA and
protein level (Fig. 5E).
Fig. 4. Restoration of miR-217 induced MET in TGF-β1 treated PC cells, while inhibition of miR-217 induced EMT in PC cells. (A) Quantitative real-time PCR showed that
the expression of miR-217 was signiﬁcantly increased after transfection of miR-217 mimic; (B) Western blot showed that restoration of miR-217 increased the expression
of epithelial marker (E-cadherin) and decreased the expression of mesenchymal markers (N-cadherin and MMP-2) in TGF-β1 treated BxPC-3 and PANC-1 cells (BxPC-3-
T72h and PANC-1-T72h cells); (C) Restoration of miR-217 led to decreased invasion (left) and migration ability (middle), as well as cell motility (right) in BxPC-3-T72h and
PANC-1-T72h cells; (D) Quantitative real-time PCR showed that expression of miR-217 was signiﬁcantly decreased after transfection of miR-217 inhibitor; (E) Western blot
showed that the inhibition of miR-217 decreased the expression of epithelial marker (E-cadherin) and increased the expression of mesenchymal markers (N-cadherin and
MMP-2) in BxPC-3 and PANC-1 cells; (F) Inhibition of miR-217 led to increased invasion (left) and migration (middle) ability, as well as cell motility (right) in BxPC-3 and
PANC-1 cells. U6 was used as the endogenous control for miR-217 and GAPDH for E-cadherin and N-cadherin. Values are signiﬁcant at *p < 0.05.
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Knockdown of SIRT1 induced MET in TGF-β1 treated PC cells and
restrained the EMT-promoting effect of miR-217 inhibitor in PC cells
To further demonstrate whether miR-217 could regulate EMT
through targeting SIRT1; SIRT1 expression was down-regulated with
SIRT1-siRNA in BxPC-3-T72h and PANC-1-T72h cells. After knock-
down of SIRT1, the BxPC-3-T72h and PANC-1-T72h cells showed a
higher expression of E-cadherin, and a lower expression of
N-cadherin, Snail and ZEB1, whereas there was no signiﬁcant dif-
ference in MMP-2 expression (Fig. 6A and B). Unsurprisingly,
knockdown of SIRT1 led to a marked decrease in the invasion, mi-
gration and cell motility of PANC-1-T72h cells (Fig. 6C).
Additionally, to further validate if SIRT1 is the major down-
stream effector of miR-217 in the EMT process, we examined if
inhibition of miR-217 was able to promote EMT of PC cells in the
absence of SIRT1. As expected, the miR-217 inhibitor failed to
upregulate SIRT1 expression (Fig. 6D and E) and also could not induce
EMT process in SIRT1-knockdown PC cells (Fig. 6F).
Therefore, all of the above results intensively indicated that the
overexpressed TGF-β1 in microenvironment of CP and PC trig-
gered the deregulatedmiR-217-SIRT1 pathway, whichmight further
induce EMT process in tumorigenesis of PC.
Correlation between miR-217 expression and clinicopathological
characteristics of patients with pancreatic cancer
To further identify the roles of miR-217 in the progression of PC,
the relationship between miR-217 expression and clinicopatho-
logical characteristics of PC patient was analyzed. We differentiated
“high level” and “low level” by the fold change for miR-217 in PC
tissues as shown in Fig. 3A. The “high level” means higher than the
average level of NP, while the low level means lower than the average
expression level in NP. As shown in Table 1, miR-217 expression was
found to be signiﬁcantly lower in PC tissues with advanced tumor
stage, lymphatic invasion, vascular inﬁltration and distant metas-
tasis. However, there was no signiﬁcant correlation between miR-
217 and other clinicopathological characteristics of PC including sex,
age, tumor size, and histologic grading.
Discussion
One of the new points in this research is that it is the ﬁrst to
demonstrate active EMT proﬁles both in CP and PC tissues. More-
over, the present study also validated that TGF-β1, the pivotal
cytokine in microenvironment of CP and PC, triggers deregulated
Fig. 5. SIRT1 was the direct target of miR-217. (A) Illustration of SIRT1 3’UTR as well as the seed sequence of miR-217 showing the predicted target region on the 3’UTR of
SIRT1 mRNA; (B) Luciferase reporter assay showed that overexpression of miR-217 in PANC-1 cells led to decreased activity of SIRT1 3’UTR-luciferase construct. The graphs
represent data from three separate experiments. (C) The miR-217 was antagonistically associated SIRT1 expression (r = −0.7043); (D) Quantitative real-time PCR and western
blot showed that expression of SIRT1 was signiﬁcantly increased in TGF-β1 treated BxPC-3 and PANC-1 cells in a time-dependent manner. (E) Overexpression of miR-217
signiﬁcantly decreased SIRT1 expression both in mRNA and protein level in BxPC-3-T72h and PANC-1-T72h cells, while SIRT1 expression signiﬁcantly increased after inhi-
bition of miR-217 in BxPC-3 and PANC-1 cells. U6 was used as the endogenous control for miR-217 and GAPDH for SIRT1. Graphs represent average of three independent
experiments. Values are signiﬁcant at *p < 0.05.
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miR-217–SIRT1 pathway, which continually contributes to tumori-
genesis of pancreatic cancer by promoting EMT process.
Accumulating data support TGF-β1 induced EMT as a link
between inﬂammation and cancer [24]. Previous study also showed
overexpression of TGF-β1 in murine pancreas induced CP [25,26].
Additionally, Friess et al. reported that TGF-β1 overexpressed in PC
tissues contributed to disease progression [11]. Therefore, the present
study applied the TGF-β1 induced EMT to simulate the inﬂamma-
tionmicroenvironment induced EMT in CP and PC. Very interestingly,
the miR-217 was remarkably down-regulated in the TGF-β1 treated
Fig. 6. Knockdown of SIRT1 induced MET in TGF-β1 treated PC cells and restrained the EMT-promoting effect of miR-217 inhibitor. (A) Quantitative real-time PCR showed
that the expression of SIRT1 mRNA was signiﬁcantly decreased after transfection of siSIRT1 in PANC-1-T72h cells; (B) Western blot showed E-cadherin was signiﬁcantly
increased, while the N-cadherin, Snail and ZEB1 were obviously decreased after knockdown of SIRT1 in PANC-1-T72h cells, respectively. There was no signiﬁcant difference
in MMP-2 expression in the protein level; (C) PANC-1-T72h cells showed decreased invasion (left), migration ability (middle) and cell motility (right) after knockdown of
SIRT1. (D) After treated with siSIRT1, SIRT1 was knockdown in PANC-1 cells, while the secondary miR-217 inhibitor did not increase the SIRT1 expression in those cells. (E)
Western blot demonstrated miR-217 did not change the expression of E-cadherin, N-cadherin and MMP2 in SIRT1-knockdown PANC-1 cells. (F) No signiﬁcant change was
shown in invasion, migration and motility in SIRT1-knockdown PANC-1 cells. U6 was used as the endogenous control for miR-217 and GAPDH for E-cadherin and N-cadherin.
Values are signiﬁcant at *p < 0.05.
Table 1
Relationship between miR-217 expression and clinicopathological factors in PC patients.
Parameters miR-217 expression P1* Mean fold
change ± SEM
P2**
High Low
Sex 0.5254 0.7413
Male (n = 31) 8 23 −0.3974 ± 0.0570
Female (n = 23) 4 19 −0.4305 ± 0.0864
Age (years) 0.7321 0.6811
≤ 60 (n = 17) 3 14 −0.4415 ± 0.0969
>60 (n = 37) 9 28 −0.3977 ± 0.0564
Tumor size (cm) 0.7477 0.8819
≤ 2 (n = 30) 6 24 −0.4181 ± 0.0611
>2 (n = 24) 6 18 −0.4033 ± 0.0803
Histologic grading 0.3066 0.2219
High/moderate (n = 19) 6 13 −0.3301 ± 0.0960
Poor (n = 35) 6 29 −0.4557 ± 0.0540
Stage 0.0123* 0.0326*
Stage I or II (n = 18) 8 10 −0.2652 ± 0.0838
Stage III or IV (n = 36) 4 32 −0.4847 ± 0.0569
Lymphatic invasion 0.0245* 0.0279*
Positive (n = 25) 2 23 −0.5260 ± 0.0612
Negative (n = 29) 10 19 −0.3128 ± 0.0698
Vascular inﬁltration 0.0194* 0.0024*
Positive (n = 27) 2 25 −0.5552 ± 0.0572
Negative (n = 27) 10 17 −0.2678 ± 0.0695
Distant metastasis 0.0181* 0.0217*
Positive (n = 21) 1 20 −0.5765 ± 0.0682
Negative (n = 33) 11 22 −0.3065 ± 0.0609
* P1 calculated by Chi-square test.
** P2 calculated by t test.
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PC cells, which was coincident with the results in tissue samples.
Similarly, inhibition of miR-217 could also induce an EMT-like trans-
formation in pancreatic cancer cells, which was similar to the TGF-
β1 incubation. Moreover, restoration of miR-217 induced a signiﬁcant
MET-like transformation in TGF-β1 treated pancreatic cancer cells.
These results intensively implied that the overexpressed TGF-β1
in inﬂammation microenvironment might down-regulate miR-
217 and then promote the EMT process in CP and PC. Byles et al.
showed that SIRT1 could regulate EMT in prostate cancer cells
through cooperationwith the EMT inducing transcription factor, ZEB1
[21]. Our previous results also showed that SIRT1 contributed to the
metastasis and carcinogenesis of PC. Since SIRT1 was the poten-
tial target of miR-217, we speculated that down-regulated miR-
217 contributed to inﬂammation induced EMT by absenting the
inhibition for SIRT1 expression. As expected, the CP and PC tissues
demonstrated a signiﬁcant inverse correlation betweenmiR-217 and
SIRT1. Consistently, our present results showed that both TGF-β1
incubation and miR-217 inhibition signiﬁcantly increased SIRT1 ex-
pression, while restoration of miR-217 obviously decreased its
expression. On the other hand, knockdown of SIRT1 effectively
induced MET-like transformation in TGF-β1 treated PC cells. More-
over, miR-217 inhibitor failed to induce SIRT1 overexpression and
EMT-like process in SIRT1 knock-down PC cells. Additionally, we
identiﬁed a mechanistic link between miR-217 and SIRT1 mRNA
using dual luciferase reporter assay. Therefore, these results inten-
sively suggested that miR-217 regulated EMT by directly targeting
SIRT1.
Furthermore, the evaluation of clinicopathological characteris-
tics of PC patients displayed that the deregulatedmiR-217 expression
was related to advanced clinical stage, lymphatic and vascular in-
ﬁltration, as well as distant metastasis. Since EMT facilitates the
tumorigenesis and tumor metastasis, these data further con-
ﬁrmed that miR-217 plays a crucial role in mediating EMT process
in response to the inﬂammatory environment of chronic pancre-
atitis and pancreatic cancer, which might contribute to the
tumorigenesis and progression of pancreatic cancer.
Collectively, our present study indicates that the inﬂammatory
microenvironment induced dysregulation of the miR-217–SIRT1
pathway might contribute to the EMT in CP and PC and then in-
volved in the tumorigenesis of PC. Furthermore, miR-217 may serve
as a novel therapeutic target and prognostic marker for PC.
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